Veeva：2024年通过更智能的现场规划最大化数字渠道报告（英文版）

Digital engagement is not a novel concept in the life sciences industry. As early as 2016, 90% of the industry1 believed that “digital business is an enabler of strategic growth.” Today, 87% of HCPs prefer either a completely virtual or a hybrid virtual engagement model with sales reps.2 Veeva Pulse Data shows that digital engagement channels have been on the rise in the past year. In March 2021, pharma reps around the world sent over eight million rep-generated emails and conducted over 600,